AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (December 21, 2007). doi:10.1152/ajpheart.00233.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/H986    most recent
00233.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knaapen, P.
Right arrow Articles by Visser, F. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knaapen, P.
Right arrow Articles by Visser, F. C
Submitted on February 22, 2007
Accepted on December 17, 2007

Determinants of Coronary Microvascular Dysfunction in Symptomatic Hypertrophic Cardiomyopathy

Paul Knaapen1*, Tjeerd Germans1, Paolo G. Camici2, Ornella E Rimoldi2, Folkert J ten Cate3, Jurrien M ten Berg4, Pieter A Dijkmans1, Ronald Boellaard5, Willem G van Dockum1, Marco J.W. Gotte1, Jos W.R. Twisk1, Albert C van Rossum1, Adriaan A Lammertsma5, and Frans C Visser1

1 Cardiology, VU University Medical Center, Amsterdam, Netherlands
2 MRC Clinical Science Center and National Heart and Lung Institute, Imperial College, Hammersmith Campus, London, United Kingdom
3 Department of Cardiology, Thoraxcenter Erasmus Medical Center, Rotterdam, the Netherlands, Rotterdam, Netherlands
4 Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands, Nieuwegein, Netherlands
5 Nuclear Medicine and PET Research, VU University Medical Center, Amsterdam, Netherlands

* To whom correspondence should be addressed. E-mail: p.knaapen{at}vumc.nl.

Objectives. Hyperemic myocardial blood flow (MBF) is impaired in hypertrophic cardiomyopathy (HCM) despite normal epicardial coronary arteries, which indicates microvascular dysfunction. The aim of the present study was to determine the relative contribution of extravascular compressive forces to microvascular dysfunction in HCM. Methods. Eighteen patients with symptomatic HCM and normal coronary arteries and 10 age matched healthy volunteers were studied with PET to quantify resting and hyperemic MBF at a subendocardial and subepicardial level. In HCM patients, MRI was performed to determine LV mass (LVMI) and volumes, echocardiography to assess diastolic perfusion time, heart catheterization to measure outflow tract gradient (LVOTG) and LV pressures, and serum NT-proBNP as a biochemical marker of LV wall stress. Results. Hyperemic MBF was blunted in HCM vs. controls (2.26 ± 0.97 vs. 2.93 ± 0.64 mL / min / g, p<0.05). In contrast to controls (1.38 ± 0.15 to 1.25 ± 0.19, p=NS), the endo-to-epi MBF ratio decreased significantly in HCM during hyperemia (1.20 ± 0.11 to 0.88 ± 0.18, p<0.01). This pattern was similar for hypertrophied septum and lateral wall. Hyperemic MBF was inversely correlated with LVOTG, NT-proBNP, left atrial volume index, and LVMI (all p<0.01). Multivariate regression analysis, however, revealed that only LVMI and NT-proBNP were independently related to hyperemic MBF, with greater impact at the subendocardial myocardial layer. Conclusions. Hyperemic MBF is more severely impaired at the subendocardial level in HCM patients. The level of impairment is related to markers of increased hemodynamic LV loading conditions and LV mass. These observations suggest that, next to reduced capillary density caused by hypertrophy, extravascular compressive forces contribute to microvascular dysfunction in HCM patients.




This article has been cited by other articles:


Home page
Eur Heart JHome page
F. Cambronero, F. Marin, V. Roldan, D. Hernandez-Romero, M. Valdes, and G. Y.H. Lip
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis
Eur. Heart J., January 9, 2009; (2009) ehn538v1.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
I. Heinonen, S. V. Nesterov, K. Liukko, J. Kemppainen, K. Nagren, M. Luotolahti, P. Virsu, V. Oikonen, P. Nuutila, U. M. Kujala, et al.
Myocardial blood flow and adenosine A2A receptor density in endurance athletes and untrained men
J. Physiol., November 1, 2008; 586(21): 5193 - 5202.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.